Clinical Analysis of Prognostic Factors of Patients with Perforated Gastric Cancers

ZHANG Hao,LI Qiang,XUE Hui-chao,WANG Jian-guo
DOI: https://doi.org/10.3877/cma.j.issn.1674-3946.2012.03.055
2012-01-01
Abstract:Objective To clarify the postoperative survival of patients with perforated gastric cancers and to investigate the prognostic factors. Methods Clinical data of 61 patients with perforated gastric cancers who underwent emergent surgical treatments from January 2000 to July 2011 were analyzed retrospectively by the Cox proportional hazards model. Results The median of postoperative survival was 120 days, and 1-, 3- and 5-year-survival rates were 31.1% (19/61), 3.3% (2/61) and 0(0/61) respectively. Multivariant Cox analysis showed that staging was the most significant prognostic factor for perforated gastric cancer. Compared to Stage Ⅱ, the prognosis of stage Ⅲ (OR=4.875, P=0.040) and stage Ⅳ (OR=9.386, P=0.006) was worse. Compared to radical gastrectomy, the OR of prime repair and palliative surgery were 3.937 and 2.347 respectively (P0.05). Furthermore, co-morbidity was also a predictor (OR=4.337, P=0.002). Conclusions Patients with perforated gastric cancers have a poor survival rate, and both staging and surgical options are the significant prognostic factors. Prime radical gastrectomy can be performed under appropriate conditions; but if there is a non-resectable tumor, palliative gastrectomy is also indicated.
What problem does this paper attempt to address?